Comparison of three rapamycin dosing schedules in A/J Tsc2(+/- )mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous...

por Woodrum, Chelsey, Nobil, Alison, Dabora, Sandra L
Publicado 2010

Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model

por Rauktys, Aubrey, Lee, Nancy, Lee, Laifong, Dabora, Sandra L
Publicado 2008

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779

por Messina, Michael P, Rauktys, Aubrey, Lee, Laifong, Dabora, Sandra L
Publicado 2007

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models

por Lee, Nancy, Woodrum, Chelsey L, Nobil, Alison M, Rauktys, Aubrey E, Messina, Michael P, Dabora, Sandra L
Publicado 2009

Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis

por Malinowska, Izabela A., Lee, Nancy, Kumar, Vidhya, Thiele, Elizabeth A., Franz, David Neal, Ashwal, Stephen, Sagalowsky, Arthur, DiMario, Francis J., Cutler, Drew, Krueger, Darcy, Camposano, Susana, Paolini, Jan, Dabora, Sandra L.
Publicado 2013

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease

por Dabora, Sandra L., Franz, David Neal, Ashwal, Stephen, Sagalowsky, Arthur, DiMario, Francis J., Miles, Daniel, Cutler, Drew, Krueger, Darcy, Uppot, Raul N., Rabenou, Rahmin, Camposano, Susana, Paolini, Jan, Fennessy, Fiona, Lee, Nancy, Woodrum, Chelsey, Manola, Judith, Garber, Judy, Thiele, Elizabeth A.
Publicado 2011